Evidence map›Paper›PMID 42845195›Full record

ArticleJournal of microbiology and biotechnology2026

Mechanism of Taohong Siwu Decoction in Alleviating PD-Related Cellular Damage based on the MAPK Signaling Pathway.

Pei Peng, Yongjun Chen, Bohong Hu, Chao Zheng, Xingcheng Dong, Ji Liang

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pei PengDepartment of Medicine Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde 415000, Hunan, P.R. China.
Yongjun ChenDepartment of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde 415000, Hunan, P.R. China.
Bohong HuDepartment of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde 415000, Hunan, P.R. China.
Chao ZhengDepartment of Imaging, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde 415000, Hunan, P.R. China.
Xingcheng DongDepartment of Orthopedics, Dushu Lake Hospital Affiliated to Soochow University (Suzhou Dushu Lake Hospital), Medical Center of Soochow University, Suzhou 215125, Jiangsu, P.R. China.
Ji LiangDepartment of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde 415000, Hunan, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the effects of Taohong Siwu Decoction (THSWD) on apoptosis, viability, and oxidative stress status in a 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y cell injury model, and to analyze the potential involvement of stress-related MAPK (p38/JNK) signaling, specifically p38 and JNK, in its cytoprotective effects. A Parkinson's disease (PD)-related neurotoxic cell injury model was established by exposing SH-SY5Y cells with 6-OHDA. After administering different doses of THSWD, the mRNA expression levels of apoptosis-related genes were quantified by quantitative real-time PCR, apoptotic cell proportions were assessed by flow cytometry, and cell viability was evaluated using the CCK-8 assay. In parallel, intracellular oxidative stress indicators, including ROS, MDA, and antioxidant defense indicators, including SOD, CAT, and GSH, were measured. A drug-component-target-disease network was constructed using network pharmacology methods, followed by protein-protein interaction analysis and Gene Ontology and KEGG pathway enrichment analyses to identify potential signaling pathways. Western blot analysis was performed to assess the phosphorylation levels of p38 and JNK proteins, and mechanistic validation was further conducted using the p38 inhibitor BIRB796. Under 6-OHDA-induced SH-SY5Y cell injury conditions, THSWD treatment significantly downregulated the mRNA expression of

Indexed as

Drugs, Chinese HerbalMAP Kinase Signaling SystemParkinson DiseaseAntioxidantsApoptosisCell Line, TumorCell SurvivalHumansNetwork PharmacologyNeuroprotective AgentsOxidative StressOxidopaminep38 Mitogen-Activated Protein KinasesReactive Oxygen SpeciesAntioxidantsDrugs, Chinese HerbalNeuroprotective AgentsOxidopaminep38 Mitogen-Activated Protein KinasesReactive Oxygen Species6-OHDAMAPK signaling pathwayNeuronal apoptosisParkinson’s diseaseSH-SY5Y cellsTaohong Siwu decoction

Identifiers

PMID42845195
PMCPMC13669511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.